.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Novartis
Dow
Federal Trade Commission
Fuji
Covington
US Army
Citi
Cantor Fitzgerald
Harvard Business School

Generated: July 27, 2017

DrugPatentWatch Database Preview

ALAMAST Drug Profile

« Back to Dashboard

What is the patent landscape for Alamast, and what generic Alamast alternatives are available?

Alamast is a drug marketed by Santen and is included in one NDA.

The generic ingredient in ALAMAST is pemirolast potassium. Additional details are available on the pemirolast potassium profile page.

Summary for Tradename: ALAMAST

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list49
Patent Applications: see list100
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ALAMAST at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Santen
ALAMAST
pemirolast potassium
SOLUTION/DROPS;OPHTHALMIC021079-001Sep 24, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ALAMAST

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Santen
ALAMAST
pemirolast potassium
SOLUTION/DROPS;OPHTHALMIC021079-001Sep 24, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Julphar
Johnson and Johnson
Colorcon
Medtronic
US Army
Daiichi Sankyo
Dow
Federal Trade Commission
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot